PROCEPT BioRobotics Corporation
PRCT
$41.14
$0.621.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.86% | 12.75% | 13.68% | 6.10% | 0.81% |
| Total Depreciation and Amortization | 21.12% | 31.61% | 37.48% | 61.77% | 72.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.05% | 76.27% | 69.35% | 30.02% | 22.63% |
| Change in Net Operating Assets | -155.05% | -39.78% | -80.90% | 5.73% | 34.89% |
| Cash from Operations | 9.31% | 19.60% | 8.14% | 15.47% | 16.04% |
| Capital Expenditure | 65.35% | 80.29% | 82.51% | 31.15% | -33.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 65.35% | 80.29% | 82.51% | 31.15% | -33.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.92% | 5.20% | 7.35% | -92.51% | 3,306.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.92% | 5.20% | 7.35% | -92.38% | 7,518.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.29% | 106.79% | 121.20% | -340.57% | 152.97% |